Astera Labs (NASDAQ:ALAB – Get Free Report) is expected to be posting its quarterly earnings results after the market closes on Monday, February 10th. Analysts expect Astera Labs to post earnings of $0.26 per share and revenue of $127.91 million for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.06. The business had revenue of $113.10 million for the quarter, compared to analyst estimates of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The firm’s quarterly revenue was up 47.1% on a year-over-year basis. On average, analysts expect Astera Labs to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Astera Labs Price Performance
ALAB stock opened at $101.42 on Monday. The company’s 50-day moving average is $122.46 and its 200-day moving average is $80.18. Astera Labs has a 1 year low of $36.22 and a 1 year high of $147.39.
Wall Street Analyst Weigh In
Read Our Latest Stock Analysis on Astera Labs
Insiders Place Their Bets
In related news, General Counsel Philip Mazzara sold 2,513 shares of Astera Labs stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $90.81, for a total value of $228,205.53. Following the sale, the general counsel now owns 248,745 shares of the company’s stock, valued at approximately $22,588,533.45. The trade was a 1.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Stefan A. Dyckerhoff sold 50,000 shares of the firm’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $89.70, for a total value of $4,485,000.00. Following the completion of the sale, the director now directly owns 129,617 shares of the company’s stock, valued at $11,626,644.90. This represents a 27.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,690,452 shares of company stock valued at $167,581,256.
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
See Also
- Five stocks we like better than Astera Labs
- How to Invest in Blue Chip Stocks
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- What does consumer price index measure?
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- Airline Stocks – Top Airline Stocks to Buy Now
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.